 James Feinstein
Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nervous System Diseases | 8 | 2024 | 253 | 3.690 |
Why?
| | Polypharmacy | 10 | 2023 | 74 | 3.260 |
Why?
| | Medicaid | 11 | 2024 | 411 | 2.870 |
Why?
| | Chronic Disease | 10 | 2022 | 1598 | 2.510 |
Why?
| | Epidermolysis Bullosa | 7 | 2023 | 41 | 2.350 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 5 | 2024 | 242 | 2.130 |
Why?
| | International Classification of Diseases | 5 | 2023 | 118 | 1.930 |
Why?
| | Medication Therapy Management | 3 | 2023 | 67 | 1.700 |
Why?
| | Outpatients | 3 | 2024 | 330 | 1.370 |
Why?
| | Child | 54 | 2024 | 18537 | 1.350 |
Why?
| | Delivery of Health Care | 3 | 2023 | 847 | 1.190 |
Why?
| | Drug Interactions | 6 | 2024 | 347 | 1.160 |
Why?
| | Physician-Patient Relations | 5 | 2011 | 467 | 1.110 |
Why?
| | Neurodevelopmental Disorders | 3 | 2019 | 109 | 1.100 |
Why?
| | Child, Preschool | 32 | 2024 | 9164 | 1.060 |
Why?
| | Epidermolysis Bullosa Dystrophica | 2 | 2023 | 21 | 1.050 |
Why?
| | Prescription Drugs | 3 | 2017 | 116 | 1.030 |
Why?
| | Sleep Wake Disorders | 2 | 2016 | 233 | 0.850 |
Why?
| | Pediatrics | 6 | 2022 | 985 | 0.840 |
Why?
| | Parents | 2 | 2020 | 1208 | 0.840 |
Why?
| | Cholinergic Antagonists | 1 | 2022 | 27 | 0.840 |
Why?
| | Infant | 26 | 2022 | 7992 | 0.820 |
Why?
| | Inappropriate Prescribing | 1 | 2022 | 52 | 0.810 |
Why?
| | Retrospective Studies | 30 | 2024 | 12615 | 0.790 |
Why?
| | Adolescent | 32 | 2024 | 17935 | 0.760 |
Why?
| | Prescription Drug Overuse | 1 | 2020 | 11 | 0.750 |
Why?
| | Drug Utilization | 2 | 2019 | 167 | 0.740 |
Why?
| | Drug Prescriptions | 2 | 2020 | 241 | 0.720 |
Why?
| | Cross-Sectional Studies | 12 | 2024 | 4447 | 0.690 |
Why?
| | Symptom Assessment | 1 | 2020 | 121 | 0.680 |
Why?
| | Ambulatory Care | 4 | 2023 | 479 | 0.680 |
Why?
| | Drug Administration Schedule | 1 | 2021 | 724 | 0.670 |
Why?
| | Humans | 68 | 2024 | 115859 | 0.670 |
Why?
| | Analgesics | 1 | 2020 | 157 | 0.660 |
Why?
| | Cohort Studies | 13 | 2024 | 4960 | 0.650 |
Why?
| | Critical Illness | 1 | 2024 | 648 | 0.640 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 250 | 0.630 |
Why?
| | Pharmaceutical Preparations | 2 | 2023 | 169 | 0.620 |
Why?
| | Drug Costs | 1 | 2019 | 91 | 0.620 |
Why?
| | Hospitalization | 5 | 2022 | 1764 | 0.600 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2022 | 577 | 0.580 |
Why?
| | Health Services Needs and Demand | 1 | 2019 | 249 | 0.580 |
Why?
| | Health Priorities | 1 | 2017 | 34 | 0.560 |
Why?
| | Medication Adherence | 1 | 2021 | 537 | 0.550 |
Why?
| | Self-Injurious Behavior | 3 | 2023 | 115 | 0.540 |
Why?
| | Skin Neoplasms | 1 | 2022 | 760 | 0.500 |
Why?
| | United States | 19 | 2024 | 12319 | 0.480 |
Why?
| | Software | 1 | 2018 | 542 | 0.460 |
Why?
| | Male | 36 | 2024 | 56103 | 0.460 |
Why?
| | Terminally Ill | 2 | 2010 | 33 | 0.410 |
Why?
| | Algorithms | 2 | 2022 | 1494 | 0.400 |
Why?
| | Severity of Illness Index | 4 | 2020 | 2590 | 0.400 |
Why?
| | Analgesics, Opioid | 1 | 2019 | 783 | 0.400 |
Why?
| | Female | 32 | 2023 | 60070 | 0.380 |
Why?
| | Biomedical Research | 1 | 2017 | 589 | 0.370 |
Why?
| | Hospitals, Pediatric | 7 | 2020 | 478 | 0.370 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2201 | 0.360 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 1842 | 0.350 |
Why?
| | Mortality | 2 | 2009 | 290 | 0.330 |
Why?
| | Caregivers | 3 | 2023 | 713 | 0.330 |
Why?
| | Professional-Family Relations | 2 | 2009 | 138 | 0.320 |
Why?
| | Home Care Services | 2 | 2022 | 226 | 0.320 |
Why?
| | Practice Patterns, Physicians' | 1 | 2017 | 1182 | 0.310 |
Why?
| | Attitude to Death | 3 | 2007 | 60 | 0.310 |
Why?
| | Child Mortality | 1 | 2007 | 13 | 0.300 |
Why?
| | Terminal Care | 2 | 2011 | 212 | 0.300 |
Why?
| | Patient Preference | 1 | 2010 | 171 | 0.300 |
Why?
| | Autopsy | 1 | 2007 | 86 | 0.300 |
Why?
| | Databases, Factual | 6 | 2024 | 1137 | 0.270 |
Why?
| | Cause of Death | 1 | 2007 | 368 | 0.260 |
Why?
| | Child Welfare | 1 | 2007 | 198 | 0.260 |
Why?
| | Medical History Taking | 1 | 2005 | 115 | 0.250 |
Why?
| | Risk Assessment | 5 | 2020 | 2992 | 0.250 |
Why?
| | Education, Medical, Undergraduate | 1 | 2007 | 179 | 0.230 |
Why?
| | Internship and Residency | 2 | 2011 | 957 | 0.230 |
Why?
| | House Calls | 1 | 2005 | 131 | 0.230 |
Why?
| | Ontario | 1 | 2024 | 108 | 0.230 |
Why?
| | Family | 1 | 2007 | 597 | 0.230 |
Why?
| | Pharmacogenomic Testing | 1 | 2024 | 54 | 0.220 |
Why?
| | Patient Safety | 3 | 2023 | 276 | 0.220 |
Why?
| | World Health Organization | 1 | 2023 | 106 | 0.210 |
Why?
| | Seizures | 1 | 2005 | 344 | 0.210 |
Why?
| | Patient Discharge | 3 | 2021 | 770 | 0.200 |
Why?
| | Anemia | 1 | 2023 | 144 | 0.200 |
Why?
| | Canada | 2 | 2020 | 337 | 0.190 |
Why?
| | Physicians | 1 | 2009 | 777 | 0.190 |
Why?
| | Age Factors | 4 | 2021 | 2911 | 0.190 |
Why?
| | Child, Hospitalized | 1 | 2021 | 39 | 0.190 |
Why?
| | Pseudomonas aeruginosa | 1 | 2023 | 303 | 0.190 |
Why?
| | Multimorbidity | 1 | 2021 | 30 | 0.190 |
Why?
| | Behavioral Symptoms | 1 | 2020 | 40 | 0.180 |
Why?
| | Bronchiolitis | 1 | 2021 | 83 | 0.170 |
Why?
| | Critical Care | 1 | 2024 | 480 | 0.170 |
Why?
| | Data Collection | 2 | 2020 | 637 | 0.160 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2020 | 116 | 0.160 |
Why?
| | Young Adult | 7 | 2020 | 10508 | 0.160 |
Why?
| | Suicidal Ideation | 1 | 2023 | 399 | 0.160 |
Why?
| | Psychotropic Drugs | 1 | 2019 | 54 | 0.160 |
Why?
| | Colorado | 2 | 2020 | 4122 | 0.160 |
Why?
| | Programming Languages | 1 | 2018 | 22 | 0.160 |
Why?
| | Biopsy, Needle | 1 | 2019 | 183 | 0.160 |
Why?
| | Health Services Research | 2 | 2019 | 377 | 0.160 |
Why?
| | Esophageal Stenosis | 1 | 2018 | 44 | 0.160 |
Why?
| | Dilatation | 1 | 2018 | 59 | 0.160 |
Why?
| | Palliative Care | 3 | 2011 | 642 | 0.150 |
Why?
| | North America | 1 | 2019 | 263 | 0.150 |
Why?
| | Fluoroscopy | 1 | 2018 | 141 | 0.150 |
Why?
| | Vulnerable Populations | 1 | 2019 | 137 | 0.150 |
Why?
| | Age Distribution | 1 | 2019 | 341 | 0.150 |
Why?
| | Sex Distribution | 1 | 2019 | 337 | 0.150 |
Why?
| | Patient-Centered Care | 1 | 2023 | 477 | 0.150 |
Why?
| | Nursing Staff, Hospital | 2 | 2011 | 124 | 0.150 |
Why?
| | Antiviral Agents | 1 | 2023 | 651 | 0.150 |
Why?
| | Esophagoscopy | 1 | 2018 | 183 | 0.150 |
Why?
| | Child Health | 1 | 2019 | 134 | 0.140 |
Why?
| | Case Management | 1 | 2017 | 62 | 0.140 |
Why?
| | Influenza, Human | 1 | 2023 | 549 | 0.140 |
Why?
| | Fee-for-Service Plans | 1 | 2017 | 79 | 0.140 |
Why?
| | Infant, Newborn | 8 | 2022 | 5084 | 0.140 |
Why?
| | Child Health Services | 3 | 2022 | 180 | 0.140 |
Why?
| | Esophagus | 2 | 2018 | 226 | 0.140 |
Why?
| | Managed Care Programs | 1 | 2017 | 135 | 0.140 |
Why?
| | Staphylococcal Infections | 1 | 2020 | 338 | 0.140 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 325 | 0.140 |
Why?
| | Anti-Bacterial Agents | 2 | 2022 | 1486 | 0.130 |
Why?
| | Sex Factors | 2 | 2019 | 1741 | 0.130 |
Why?
| | Neoplasms | 1 | 2009 | 2114 | 0.130 |
Why?
| | Drug Labeling | 1 | 2015 | 42 | 0.130 |
Why?
| | Health Care Costs | 1 | 2019 | 384 | 0.130 |
Why?
| | Survival Analysis | 1 | 2019 | 1218 | 0.130 |
Why?
| | Drug Therapy, Combination | 2 | 2018 | 962 | 0.130 |
Why?
| | Pneumonia | 1 | 2021 | 576 | 0.130 |
Why?
| | Telemedicine | 1 | 2023 | 667 | 0.130 |
Why?
| | Autism Spectrum Disorder | 1 | 2020 | 322 | 0.130 |
Why?
| | Pain | 1 | 2020 | 712 | 0.120 |
Why?
| | Medication Errors | 1 | 2015 | 89 | 0.120 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2016 | 147 | 0.120 |
Why?
| | Hypnotics and Sedatives | 1 | 2016 | 135 | 0.120 |
Why?
| | Immunohistochemistry | 1 | 2019 | 1644 | 0.120 |
Why?
| | Duodenum | 1 | 2014 | 63 | 0.120 |
Why?
| | Terminology as Topic | 1 | 2015 | 186 | 0.120 |
Why?
| | Insurance Claim Reporting | 1 | 2014 | 22 | 0.120 |
Why?
| | Stomach | 1 | 2014 | 101 | 0.120 |
Why?
| | Utilization Review | 1 | 2014 | 34 | 0.120 |
Why?
| | Patient Readmission | 2 | 2021 | 609 | 0.120 |
Why?
| | Mucous Membrane | 1 | 2014 | 108 | 0.120 |
Why?
| | Biomedical Technology | 1 | 2014 | 41 | 0.110 |
Why?
| | Adult | 8 | 2023 | 30814 | 0.110 |
Why?
| | Statistics as Topic | 1 | 2014 | 299 | 0.110 |
Why?
| | Quality Improvement | 1 | 2020 | 958 | 0.110 |
Why?
| | Risk Factors | 4 | 2021 | 8715 | 0.110 |
Why?
| | Lung Neoplasms | 1 | 2005 | 2206 | 0.110 |
Why?
| | Prevalence | 2 | 2019 | 2270 | 0.110 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2014 | 202 | 0.110 |
Why?
| | Mental Disorders | 1 | 2020 | 903 | 0.100 |
Why?
| | Follow-Up Studies | 2 | 2019 | 4443 | 0.100 |
Why?
| | Patient Admission | 1 | 2014 | 175 | 0.100 |
Why?
| | Incidence | 1 | 2019 | 2336 | 0.100 |
Why?
| | Quality of Life | 1 | 2023 | 2390 | 0.100 |
Why?
| | Organ Transplantation | 1 | 2014 | 161 | 0.100 |
Why?
| | Endoscopy, Digestive System | 1 | 2013 | 109 | 0.100 |
Why?
| | Disease Progression | 1 | 2019 | 2423 | 0.100 |
Why?
| | Comorbidity | 3 | 2023 | 1476 | 0.100 |
Why?
| | Attitude of Health Personnel | 2 | 2011 | 991 | 0.100 |
Why?
| | Health Services Accessibility | 1 | 2017 | 771 | 0.100 |
Why?
| | Gastrointestinal Diseases | 1 | 2013 | 184 | 0.100 |
Why?
| | Bereavement | 1 | 2011 | 49 | 0.090 |
Why?
| | Obesity | 1 | 2023 | 2523 | 0.090 |
Why?
| | Anecdotes as Topic | 1 | 2010 | 7 | 0.090 |
Why?
| | Drug Overdose | 1 | 2014 | 295 | 0.090 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2007 | 1193 | 0.080 |
Why?
| | Predictive Value of Tests | 2 | 2023 | 1813 | 0.080 |
Why?
| | Pharmacoepidemiology | 2 | 2019 | 20 | 0.080 |
Why?
| | Domestic Violence | 1 | 2008 | 45 | 0.070 |
Why?
| | Humanism | 1 | 2005 | 5 | 0.070 |
Why?
| | Shellfish | 1 | 2005 | 8 | 0.070 |
Why?
| | Adaptation, Psychological | 1 | 2010 | 551 | 0.060 |
Why?
| | Residence Characteristics | 1 | 2007 | 275 | 0.060 |
Why?
| | Health Care Surveys | 2 | 2017 | 540 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2022 | 2416 | 0.060 |
Why?
| | Adrenal Cortex Hormones | 1 | 2007 | 510 | 0.060 |
Why?
| | Cytochrome P-450 CYP2D6 | 1 | 2024 | 25 | 0.060 |
Why?
| | Anaphylaxis | 1 | 2005 | 148 | 0.050 |
Why?
| | Hospitals | 1 | 2007 | 585 | 0.050 |
Why?
| | Communication | 2 | 2023 | 749 | 0.050 |
Why?
| | Nursing Homes | 1 | 2023 | 136 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 333 | 0.050 |
Why?
| | Food Hypersensitivity | 1 | 2005 | 254 | 0.050 |
Why?
| | Iron | 1 | 2023 | 235 | 0.050 |
Why?
| | Mupirocin | 1 | 2020 | 7 | 0.050 |
Why?
| | Prognosis | 1 | 2009 | 3344 | 0.050 |
Why?
| | Consensus | 1 | 2023 | 531 | 0.050 |
Why?
| | Anxiety Disorders | 1 | 2023 | 310 | 0.040 |
Why?
| | Primary Health Care | 2 | 2022 | 1520 | 0.040 |
Why?
| | Pharmacists | 1 | 2022 | 237 | 0.040 |
Why?
| | Pharmacovigilance | 1 | 2019 | 14 | 0.040 |
Why?
| | Clinical Competence | 1 | 2005 | 924 | 0.040 |
Why?
| | Health Expenditures | 1 | 2020 | 173 | 0.040 |
Why?
| | Adolescent Health Services | 1 | 2019 | 67 | 0.040 |
Why?
| | Mental Health Services | 1 | 2022 | 326 | 0.040 |
Why?
| | Health Maintenance Organizations | 1 | 2017 | 96 | 0.040 |
Why?
| | Health Personnel | 1 | 2023 | 579 | 0.040 |
Why?
| | Observer Variation | 1 | 2018 | 298 | 0.040 |
Why?
| | Rural Population | 1 | 2020 | 448 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2020 | 386 | 0.040 |
Why?
| | Anxiety | 1 | 2023 | 854 | 0.040 |
Why?
| | Global Health | 1 | 2019 | 290 | 0.030 |
Why?
| | Logistic Models | 2 | 2013 | 1863 | 0.030 |
Why?
| | Stomach Diseases | 1 | 2014 | 19 | 0.030 |
Why?
| | Clinical Coding | 1 | 2014 | 20 | 0.030 |
Why?
| | Middle Aged | 3 | 2018 | 27078 | 0.030 |
Why?
| | Mental Health | 1 | 2020 | 571 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 682 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1725 | 0.030 |
Why?
| | Endoscopes, Gastrointestinal | 1 | 2013 | 12 | 0.030 |
Why?
| | Failure to Thrive | 1 | 2013 | 32 | 0.030 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 127 | 0.030 |
Why?
| | Abdominal Pain | 1 | 2013 | 136 | 0.030 |
Why?
| | Celiac Disease | 1 | 2014 | 266 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 6276 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1056 | 0.020 |
Why?
| | Gastroesophageal Reflux | 1 | 2013 | 235 | 0.020 |
Why?
| | Eosinophilic Esophagitis | 1 | 2014 | 295 | 0.020 |
Why?
| | Length of Stay | 1 | 2015 | 960 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1443 | 0.020 |
Why?
| | Pennsylvania | 1 | 2009 | 94 | 0.020 |
Why?
| | Nurses | 1 | 2011 | 151 | 0.020 |
Why?
| | Nurse-Patient Relations | 1 | 2007 | 45 | 0.020 |
Why?
| | Interviews as Topic | 1 | 2008 | 595 | 0.020 |
Why?
| | Regression Analysis | 1 | 2008 | 960 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2009 | 520 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2018 | 9163 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2009 | 779 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2007 | 355 | 0.010 |
Why?
|
|
Feinstein's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|